Tag:

Halozyme Therapeutics

Latest Headlines

Latest Headlines

ViroPharma, Halozyme tackle hereditary angioedema treatment

ViroPharma ( $VPHM ) and Halozyme ( $HALO ) said they have generated positive early data in a Phase II trial of a drug delivery platform used to treat hereditary angioedema, a life-threatening immune

Halozyme preps for FDA meeting on recalled drug

Halozyme and its manufacturing partner Baxter Healthcare say they've got a plan to reintroduce their withdrawn drug Hylenex. Halozyme pulled lots of the injectable drug after glass flakes were found

Halozyme calls Baxter out on recalled Hylenex

Halozyme Therapeutics is recalling its fluid absorption drug Hylenex and is pointing the finger of blame at manufacturing partner Baxter. Test vials were found to be contaminated with flakes of